Related Experiment Video
Updated: Sep 28, 2026

Diagnosis of Hirschsprung's Disease by Immunostaining Rectal Suction Biopsies for Calretinin, S100 Protein and Protein Gene Product 9.5
Published on: April 26, 2019
Growth and dietary effects on gastrointestinal symptoms in children with Hirschsprung's disease
Lovisa Telborn1,2, Irene Axelsson3, Christina Granéli4
1Department of Pediatric Surgery, Skåne University Hospital, Klinikgatan 15, Lund, S-222 42, Sweden. lovisa.telborn@med.lu.se.
Purpose:
Growth and diet are major concerns for patients with Hirschsprung's disease yet are rarely described. This study aimed to investigate self-reported growth and the dietary impact on gastrointestinal symptoms in children with Hirschsprung's disease.
Methods:
This observational cross-sectional study used a validated self-report questionnaire. All children aged 1-18 years old (n = 85) with Hirschsprung's disease treated at a national center were invited to participate.
Results:
In total, 71 children (84%) participated (median age 6 years [range 1-17]). Stunting was reported in 6 of 71 children (9%), with no significant difference between those with rectosigmoid and long-segment aganglionosis (4/58 [7%] vs. 2/13 [15%], p = 0.328). The majority (55/71; 77%) reported diet-induced gastrointestinal symptoms, again with no significant difference between the groups (43/58 [74%] vs. 12/13 [92%] p = 0.227). Of the 90 food items assessed, the most frequently reported to trigger symptoms were high in fermentable oligosaccharides, disaccharides, monosaccharides, and polyols (FODMAPs), free sugar and fat.
Conclusion:
Diet-related gastrointestinal complaints are reported frequently in children with Hirschsprung's disease, regardless of aganglionic extent. The findings highlight the need to assess growth and dietary factors in follow-up care and support further interventional studies on dietary strategies.
Related Concept Videos
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...
Drugs for Treatment of Constipation-Predominant IBS
Overview of Human Digestion
Irritable Bowel Syndrome I: Introduction
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
Assessment of the Gastrointestinal System I: Subjective Data
Health History
The initial step in assessing the GI system is obtaining a comprehensive health history. This includes inquiring about the patient's history or presence of problems related to...
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by transmural...
